The World Molecular Imaging Congress being held in Savannah, Ga., from September 18 – 21 is in full swing and bringing new focus to the worldwide molecular imaging agenda.

Cleveland Clinic Innovations has created a spin-off company to develop a preventive breast cancer vaccine based on research from Cleveland Clinic’s Lerner Research Institute.

Podiatrists who own in-office cone beam computed tomography (CBCT) imaging equipment now have a pathway to demonstrate their commitment to quality and acquire accreditation through the Intersocietal Accreditation Commission (IAC).

A new breed of versatile, portable and easy to use imaging systems will have the most significant impact on ultrasound imaging over the next five years, a recent poll of healthcare professionals by Siemens Healthcare has found.

Definiens AG, a healthcare company that advances personalized medicine through image analysis and digital pathology solutions, and Advanced Cell Diagnostics (ACD) of Hayward California, a leader in molecular pathology, announced recently the commercial launch of RNAscope® SpotStudio™, a custom-designed image analysis software application for ACD's RNAscope®Assays to detect and quantify RNA biomarkers.

Buckyballs, the soccer ball-shaped carbon nanoparticles, have shown promise for applications in medicine, but how they are created is a mystery.

Homing in on vascular cell adhesion molecule-1 (VCAM-1) expression in metastatic ovarian cancer with SPECT could gauge response to therapy and potentially improve survival, according to a study published Sept. 12 in the Journal of Nuclear Medicine.

Jubilant DraxImage, a distributor of the MAA lyophilized Technetium-99m kit, announced that as of Sept. 6 a disruption in the company’s supply chain would effectively render the technetium-synthesis kit out-of-stock until an unspecified date in October, according to a letter to customers.